Загрузка...
Antiangiogenesis therapy in ovarian cancer patients: An updated meta-analysis for 15 randomized controlled trials
BACKGROUND: Antiangiogenesis therapy has been demonstrated to prolong the free survival with tolerable toxicity. However the efficacy of these drugs in overall survival (OS) remains controversial. This study was designed to assess the overall performance of antiangiogenesis therapy in improving the...
Сохранить в:
| Опубликовано в: : | Medicine (Baltimore) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Health
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6112884/ https://ncbi.nlm.nih.gov/pubmed/30142803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011920 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|